Oxford BioMedica PLC
LSE:OXB

Watchlist Manager
Oxford BioMedica PLC Logo
Oxford BioMedica PLC
LSE:OXB
Watchlist
Price: 412.5 GBX -1.43% Market Closed
Market Cap: 434.6m GBX
Have any thoughts about
Oxford BioMedica PLC?
Write Note

Oxford BioMedica PLC
Net Change in Cash

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Oxford BioMedica PLC
Net Change in Cash Peer Comparison

Comparables:
CNTA
AUTL
BCYC
IMCR
GNS

Competitive Net Change in Cash Analysis
Latest Figures & CAGR of Competitors

Company Net Change in Cash CAGR 3Y CAGR 5Y CAGR 10Y
Oxford BioMedica PLC
LSE:OXB
Net Change in Cash
-ÂŁ48m
CAGR 3-Years
N/A
CAGR 5-Years
-22%
CAGR 10-Years
N/A
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
Net Change in Cash
-$265.6m
CAGR 3-Years
-205%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Autolus Therapeutics PLC
NASDAQ:AUTL
Net Change in Cash
-$142.4m
CAGR 3-Years
-35%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bicycle Therapeutics PLC
NASDAQ:BCYC
Net Change in Cash
$318.8m
CAGR 3-Years
43%
CAGR 5-Years
46%
CAGR 10-Years
N/A
Immunocore Holdings PLC
NASDAQ:IMCR
Net Change in Cash
ÂŁ40.2m
CAGR 3-Years
-10%
CAGR 5-Years
-1%
CAGR 10-Years
N/A
Genus PLC
LSE:GNS
Net Change in Cash
ÂŁ6.2m
CAGR 3-Years
10%
CAGR 5-Years
35%
CAGR 10-Years
4%

See Also

What is Oxford BioMedica PLC's Net Change in Cash?
Net Change in Cash
-48m GBP

Based on the financial report for Jun 30, 2024, Oxford BioMedica PLC's Net Change in Cash amounts to -48m GBP.

What is Oxford BioMedica PLC's Net Change in Cash growth rate?
Net Change in Cash CAGR 5Y
-22%

Back to Top